CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Short Interest Update

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) saw a large increase in short interest in the month of February. As of February 28th, there was short interest totalling 3,800 shares, an increase of 3,700.0% from the February 13th total of 100 shares. Based on an average daily volume of 126,800 shares, the days-to-cover ratio is currently 0.0 days.

CNBX Pharmaceuticals Stock Down 1.3 %

Shares of CNBX Pharmaceuticals stock opened at $0.01 on Friday. The stock’s fifty day simple moving average is $0.01 and its 200 day simple moving average is $0.01. CNBX Pharmaceuticals has a 12 month low of $0.01 and a 12 month high of $0.02.

CNBX Pharmaceuticals Company Profile

CNBX Pharmaceuticals Inc, a clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome.